St. Louis-born Galera Therapeutics goes public with $60M IPO

Galera Therapeutics, a Pennsylvania-based biotechnology startup that has its research and development segment in St. Louis, has raised $60 million in an initial public offering. The company, which is developing treatments to reduce the harmful effect of radiation therapy, raised the $60 million by selling 5 million shares of its common stock at $12 per share per share. In documents filed with the Securities and Exchange Commission last week, Galera said it expected to sel l its shares at between…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news